11630 SW 97 Street, Miami, Florida 33176, US

Advertising Driven Press Release Distribution

Tag: cancer

KAZIA RECOGNISES GBM AWARENESS DAY 2022 AS IT EXPANDS CLINICAL TRIAL ACTIVITY IN EUROPE AND US

Press Release

Sydney, 20 July 2022 – Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is lending its support to Glioblastoma (GBM) Awareness Day 2022 and remains firmly focused on developing a treatment that may help improve the […]

Read More>>

Cancer Molecular Diagnostics Market, Size, Share, Evaluation, 2021-2028

Press Release

Market Overview “The Global Cancer Molecular Diagnostics Market is expected to grow at a high CAGR during the forecasting period (2021-2028)”. Cancer molecular diagnostics include the detection, diagnosis, sub-classification, prognosis, and monitoring response to therapy. These techniques identify the alterations in DNA […]

Read More>>

CURATIVE BIOTECHNOLOGY ANNOUNCES IMT504 LICENSE FOR DEVELOPMENT OF PROPRIETARY NEXT-GEN COVID-19 VACCINE

Press Release

License from Mid-Atlantic BioTherapeutics for IMT504 Broadens Scope of Initial License Beyond Treatment of Symptomatic Rabies Boca Raton, FL, October 7, 2021 – Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”) announced today that the Company has reached […]

Read More>>

Neoantigen-Based Personalized Cancer Therapeutic Vaccines Report 2035: Competitive Landscape and Market Forecast to 2035 | DelveInsight

Press Release

DelveInsight’s ‘Neoantigen based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast by 2035‘ report provides an in-depth understanding of Neoantigen based Personalized Cancer therapeutic Vaccines & the Neoantigen-based personalized cancer therapeutic vaccines emerging market trends in the US, EU5 […]

Read More>>

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis

Press Release

Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access Roots Analysis is pleased […]

Read More>>

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis

Press Release

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions Roots Analysis is pleased to announce the publication […]

Read More>>

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis

Press Release

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions Roots Analysis is pleased to announce the publication […]

Read More>>

Water Tower Research to Host Theratechnologies CEO Paul Lévesque and CMO Christian Marsolais as Part of the WTR Fireside Chat Series

Press Release

The Fireside Chat will take place on Wednesday, February 10th at 2:00 pm Eastern Time. The live event will also be archived and available for replay. The Fireside Chat is open for all investors to access. “We are excited to […]

Read More>>

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis

Press Release

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions   Roots Analysis is pleased to announce the […]

Read More>>

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis

Press Release

 Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions Roots Analysis is pleased to announce the publication […]

Read More>>

Connectyx Announces Grant of License from National Institutes of Health for Use of Novel Monoclonal Antibody to Treat Glioblastoma

Press Release

Boca Raton, FL (October 16, 2020) – Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases today announced it has entered into an Exclusive Evaluation and Commercialization […]

Read More>>

Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies

Press Release

Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases, announced today the Company has signed a definitive agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT) to acquire worldwide rights […]

Read More>>

Clarity Pharmaceuticals and ImaginAb to collaborate on new cancer targets

Press Release

Sydney, Australia and Los Angeles, California 21 July 2020 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement […]

Read More>>

BRAVE & BEAUTIFUL BLOOD CANCER FOUNDATION NON-PROFIT PARTNERS WITH CITY OF LAS VEGAS FOR 1ST ANNUAL HEALTH FAMILIES FESTIVAL

Press Release

The Brave & Beautiful Blood Cancer Foundation announces its 1st annual Healthy Families Festival featuring a 1 Mile Warrior Walk in a Fight to End Blood Cancer The Brave & Beautiful Blood Cancer Foundation partners with The City of Las […]

Read More>>

Lloyd Bell Settles Medical Malpractice Case Against Kaiser Permanente

Press Release

Lloyd Bell Settles Medical Malpractice Case Against Kaiser Permanente 24-Year-Old Male Dies After Kaiser Doctors Fail to Diagnose Testicular Cancer for 6 Months ATLANTA, Ga. – October 25, 2019 – Lloyd Bell of Bell Law Firm, Georgia’s preeminent law firm […]

Read More>>

Cancer Treatment Drugs Market by Type, Top Key Players, Size, Share, Growth, Trends – Opportunity, Analysis, Forecast 2025

Press Release

Cancer Drugs and Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy Biologic Therapy, […]

Read More>>

Subscribe to Our Newsletter

For exclusive content regarding the latest trends in the world of Press Release distribution.